1. Home
  2. SUPN vs SYBT Comparison

SUPN vs SYBT Comparison

Compare SUPN & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

N/A

Current Price

$29.57

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo Stock Yards Bancorp Inc.

SYBT

Stock Yards Bancorp Inc.

N/A

Current Price

$79.01

Market Cap

2.4B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SUPN
SYBT
Founded
2005
1904
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
2014
2009

Fundamental Metrics

Financial Performance
Metric
SUPN
SYBT
Price
$29.57
$79.01
Analyst Decision
Strong Buy
Hold
Analyst Count
7
6
Target Price
$54.14
★ $87.60
AVG Volume (30 Days)
★ 2.4M
123.0K
Earning Date
10-29-2026
10-28-2026
Dividend Yield
N/A
★ 1.67%
EPS Growth
★ 8100.00
22.11
EPS
2.78
★ 3.95
Revenue
★ $1,239,000,000.00
$23,406,000.00
Revenue This Year
$51.56
$15.69
Revenue Next Year
$30.35
$9.90
P/E Ratio
★ $10.65
$19.96
Revenue Growth
★ 4.29
3.37
52 Week Low
$25.92
$61.51
52 Week High
$59.68
$89.22

Technical Indicators

Market Signals
Indicator
SUPN
SYBT
Relative Strength Index (RSI) 31.65 49.36
Support Level $25.92 $75.81
Resistance Level $51.59 $78.73
Average True Range (ATR) 2.00 1.77
MACD -0.52 -0.03
Stochastic Oscillator 19.96 34.70

Price Performance

Historical Comparison
SUPN
SYBT

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About SYBT Stock Yards Bancorp Inc.

Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.

Share on Social Networks: